Senate approves cannabis streamlining bill with new rules for licenses, canopy sizes and medical access

The Senate moved to concur with House amendments to the cannabis bill (House File 4401 / Senate File 4041), enacting a package of changes intended to streamline licensing and increase medical access. Sen. Scott Dibble, explaining the changes, said the bill clarifies that medical consultants and pharmacists may be employees or contractors at micro and meso retailers, allows transport of product to testing facilities during a 30-month transition period, and adjusts the maximum combined canopy for macro licenses on a graduated timeline ending at 45,000 square feet.

The conference changes also include an equity-investor provision that permits a party of interest to own up to 33% of up to four social equity businesses, and creates protections to ensure high-need medical products are available at micro and meso license holders within 24 hours when requested. Supporters argued the streamlining will improve access and reduce medical market shortages; opponents warned some businesses and workers could be disadvantaged by sudden changes and urged grandfathering for near-complete projects.

Senators debated canopy sizes and whether tribes or affected license applicants had adequate notice; Sen. Port and Sen. Dibble defended the rightsizing and streamlining as a way to balance market efficiency and patient access. After roll call, the motion to concur passed and final passage occurred later that day, with recorded tallies reflecting a closely divided floor.